Table 2.
CMR characteristics |
|||||||
---|---|---|---|---|---|---|---|
Control (n = 56) | CAD (n = 60) | MI (n = 55) | |||||
Cardiac function parameters | |||||||
EDV (mL) | 120.7 | (23.8) | 128.0 | (34.1) | 135.1 | (33.9) | 0.05 |
ESV (mL) | 45.2 | (13.4) | 48.1 | (16.3) | 56.2 | (20.3) | 0.002 |
LVEF (%) | 62.9 | (6.3) | 63.6 | (9.1) | 59.2 | (7.5) | 0.008 |
Cardiac adipose tissue | |||||||
EAT (mL), median (IQR) | 127.4 | (100.6–149. 6) | 141.5 | (106.8–170.5) | 124.7 | (108.3–159.3) | 0.13 |
PAT (mL), median (IQR) | 133.4 | (98.0–183.2) | 126.7 | (103.7–168.0) | 125.9 | (95.2–186.2) | 0.92 |
PEAT (mL), median (IQR) | 247.7 | (209.7–330.0) | 272.6 | (217.4–334.8) | 267.3 | (213.1–329.3) | 0.65 |
iEAT (mL/m2), median (IQR) | 66.1 | (54.4 – 77.0) | 70.9 | (55.8 – 85.5) | 67.6 | (58.6 – 82.3) | 0.18 |
iPAT (mL/m2), median (IQR) | 68.7 | (51.3–92.9) | 68.4 | (55.1 – 82.7) | 64.6 | (51.0 – 91.9) | 0.96 |
iPEAT (mL/m2), median IQR) | 131.1 | (106.6 – 166.1) | 138.0 | (117.7 – 169.0) | 140.7 | (117.0 – 163.8) | 0.71 |
Ratio EAT/PEAT, median (IQR) | 0.86 | (0.76 – 1.13) | 1.00 | (0.79 – 1.24) | 1.03 | (0.77 – 1.24) | 0.32 |
P-values for differences between the three groups were obtained using the one-way ANOVA test and Kruskal-Wallis test, depending on distribution. EDV: end-diastolic volume; EAT: epicardial adipose tissue; PAT: paracardial adipose tissue; ESV: end-systolic volume; iEAT: indexed epicardial adipose tissue; iPAT: indexed paracardial adipose tissue; iPeAT: indexed pericardial adipose tissue.